Combination of Systemic Chemotherapy with Local Stem Cell Delivered S-TRAIL in Resected Brain Tumors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of Systemic Chemotherapy with Local Stem Cell Delivered S-TRAIL in Resected Brain Tumors
Authors
Keywords
-
Journal
STEM CELLS
Volume 33, Issue 1, Pages 101-110
Publisher
Wiley
Online
2014-09-03
DOI
10.1002/stem.1834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2013) Luis Paz-Ares et al. Journal of Thoracic Oncology
- First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study
- (2012) George D. Demetri et al. EUROPEAN JOURNAL OF CANCER
- Real-time multi-modality imaging of glioblastoma tumor resection and recurrence
- (2012) Shawn Hingtgen et al. JOURNAL OF NEURO-ONCOLOGY
- Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors
- (2012) T Bagci-Onder et al. ONCOGENE
- Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects
- (2012) J. A. J. M. van de Water et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
- (2012) N. J. Szerlip et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A20 Ubiquitin Ligase–Mediated Polyubiquitination of RIP1 Inhibits Caspase-8 Cleavage and TRAIL-Induced Apoptosis in Glioblastoma
- (2012) Anita C. Bellail et al. Cancer Discovery
- Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
- (2011) Ling Qi et al. APOPTOSIS
- Heterogeneity Maintenance in Glioblastoma: A Social Network
- (2011) R. Bonavia et al. CANCER RESEARCH
- Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas
- (2011) Timo M Kauer et al. NATURE NEUROSCIENCE
- Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor–related apoptosis-inducing ligand and induces an alternative cell death pathway
- (2011) Christian E. Badr et al. NEURO-ONCOLOGY
- Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
- (2011) H. Wakimoto et al. NEURO-ONCOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
- (2010) T Trarbach et al. BRITISH JOURNAL OF CANCER
- A Dual PI3K/mTOR Inhibitor, PI-103, Cooperates with Stem Cell-Delivered TRAIL in Experimental Glioma Models
- (2010) T. Bagci-Onder et al. CANCER RESEARCH
- Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
- (2010) Zhi Huang et al. Protein & Cell
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
- Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells
- (2009) D.-H. Lee et al. CLINICAL CANCER RESEARCH
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
- (2009) L. S. Sasportas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bimodal Viral Vectors and In Vivo Imaging Reveal the Fate of Human Neural Stem Cells in Experimental Glioma Model
- (2008) K. Shah et al. JOURNAL OF NEUROSCIENCE
- Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide
- (2008) S. Hingtgen et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More